No Matches Found
No Matches Found
No Matches Found
Positive Financial Results for M K Proteins in Q3 2024, Indicating Strong Growth Potential
M K Proteins, a microcap company in the solvent extraction industry, has reported a positive financial performance in the quarter ending September 2024. With a growth of 146.99% in net sales and significant improvements in profit before and after tax, the company is showing promising results. MarketsMOJO has given a 'Hold' call for its stock, indicating steady performance in the near future.
MarketsMOJO Downgrades M K Proteins to 'Sell' Due to Flat Results and Underperformance
M K Proteins, a microcap company in the solvent extraction industry, has been downgraded to a 'Sell' by MarketsMOJO due to flat results in the June 2024 quarter and underperformance in the market. Despite positive aspects such as high management efficiency, the stock's valuation and PEG ratio suggest it may be overvalued. Majority shareholders being promoters may also raise concerns.
MarketsMOJO Upgrades M K Proteins to 'Hold' Rating Due to Strong Management Efficiency and Debt Servicing Ability
M K Proteins, a microcap company in the solvent extraction industry, has been upgraded to a 'Hold' rating by MarketsMOJO due to its high management efficiency and strong ability to service debt. Despite a negative return in the past year, the company has seen a 5% increase in profits. However, its PEG ratio suggests an overvalued stock. The company is primarily owned by its promoters and has underperformed the market in the past year. It is currently recommended to hold the stock and monitor its performance closely.
Microcap company M K Proteins sees dip in stock price, 'Sell' call by MarketsMOJO
M K Proteins, a microcap company in the solvent extraction industry, has recently hit a 52-week low of Rs. 8.07 on October 28, 2024. Despite outperforming the sector today, the stock is trading below its moving averages and has seen a decline of 69.93% in the past year, highlighting the challenges faced by the company in the current market. Investors should conduct thorough research and seek professional advice before making any decisions.
M K Proteins Hits 52-Week Low, Receives Sell Rating from MarketsMOJO
M K Proteins, a microcap company in the solvent extraction industry, has hit a 52-week low on October 23, 2024, with a Sell rating from MarketsMOJO. The stock has been on a downward trend, underperforming the sector by -1.23% and trading below all its moving averages. In the past year, it has seen a decline of -68.52%, highlighting the challenges faced in the current market conditions. Investors are advised to conduct their own research before investing.
M K Proteins Downgraded to 'Sell' by MarketsMOJO: Negative Outlook for Solvent Extraction Company.
M K Proteins, a microcap company in the solvent extraction industry, has been downgraded to a 'Sell' by MarketsMOJO due to its flat results in the quarter ending June 2024 and underperformance in the market. The stock is currently in a bearish range and has a high PEG ratio, indicating overvaluation. Investors may consider selling their shares.
MarketsMOJO Upgrades M K Proteins to 'Hold' Rating Based on Strong Management Efficiency and Debt Servicing Ability
M K Proteins, a microcap company in the solvent extraction industry, has received a 'Hold' rating from MarketsMOJO due to its high management efficiency and strong ability to service debt. However, the stock has underperformed the market in the past year and has a potentially overvalued PEG ratio. With mixed technical indicators, investors should carefully consider before investing.
M K Proteins downgraded to 'Sell' by MarketsMOJO due to flat results and bearish trend.
M K Proteins, a microcap company in the solvent extraction industry, has been downgraded to a 'Sell' by MarketsMOJO due to flat results in the June 2024 quarter and a bearish technical trend. Despite positive aspects such as high management efficiency and attractive valuation, the stock has underperformed and may not be a favorable investment option.
MarketsMOJO Upgrades M K Proteins to 'Hold' Rating Based on Strong Management Efficiency and Debt Servicing Ability
M K Proteins, a microcap company in the solvent extraction industry, has received a 'Hold' rating from MarketsMOJO due to its high management efficiency and strong ability to service debt. The company's attractive valuation and majority ownership by promoters provide stability, but recent financial results show a decline in net sales. The stock is currently in a mildly bearish range and has underperformed the market in the past year.
M K Proteins' Stock Hits 52-Week Low, Given Sell Rating by MarketsMOJO
M K Proteins, a microcap company in the solvent extraction industry, has seen a dip in its stock price, hitting a 52-week low on September 25, 2024. The stock has been given a Sell rating by MarketsMOJO and is currently trading below its moving averages. Compared to the benchmark index, the company has had a rough year with a -67.18% performance.
Microcap Company M K Proteins Sees Significant Stock Dip, Caution Advised for Investors
M K Proteins, a microcap company in the solvent extraction industry, has recently experienced a dip in its stock price, hitting a 52-week low of Rs.9.36 on September 18, 2024. The stock has been on a downward trend for the past 6 days, with a fall of -15.93%. It is currently trading below its moving averages and has underperformed the sector by -4.72%. Investors should exercise caution and conduct thorough research before investing in M K Proteins.
MarketsMOJO Downgrades M K Proteins to 'Sell' Amidst Flat Results and Bearish Trends
M K Proteins, a microcap company in the solvent extraction industry, has been downgraded to a 'Sell' by MarketsMOJO due to its flat results in the June 2024 quarter and negative stock performance. Despite some positive factors, such as high management efficiency and attractive valuation, caution is advised for potential investors.
MarketsMOJO Upgrades M K Proteins to 'Hold' Rating Based on Strong Management and Debt Servicing
M K Proteins, a microcap company in the solvent extraction industry, has received a 'Hold' rating from MarketsMOJO due to its high management efficiency and strong debt servicing ability. The stock is currently trading at a lower valuation compared to its historical average, but has seen a decline in stock price and net sales. Despite this, the company's profits have increased and it remains a 'Hold' for investors.
M K Proteins Downgraded to 'Sell' by MarketsMOJO, Underperforms Market with -62.08% Returns.
M K Proteins, a microcap company in the solvent extraction industry, has been downgraded to 'Sell' by MarketsMOJO due to flat results in June 2024 quarter, negative returns of -62.08% in the last year, and a high PEG ratio of 5.4. While the company has some positive aspects, potential investors should carefully consider all factors before making any investment decisions.
MarketsMOJO Upgrades M K Proteins to 'Hold' Rating Based on Strong Management Efficiency and Attractive Valuation
M K Proteins, a microcap company in the solvent extraction industry, has received a 'Hold' rating from MarketsMOJO on August 22, 2024. The company's high management efficiency and strong ability to service its debt have led to this upgrade. However, the stock is currently trading below its historical average and has seen a decline in its stock price. The majority shareholders are the promoters and the company's net sales have decreased in the latest quarter. The stock is currently in a mildly bearish range, with negative returns in the past year. MarketsMOJO has upgraded the stock based on its financial and technical performance.
M K Proteins Reports 24.76% Decline in Net Sales for Q1 FY25
M K Proteins, a microcap company in the solvent extraction industry, reported a decline in net sales of 24.76% for the quarter ending June 2024. This has raised concerns about the company's near-term performance, but it is important to note that this is a year-on-year comparison and may not reflect the overall performance. MarketsMOJO has given a 'Sell' call for the company, possibly due to the decline in sales. As a microcap company, M K Proteins may be more susceptible to market fluctuations. Investors should conduct their own research before making any investment decisions.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}